{"abstract": "Sanofi Aventis says its $69-a-share bid for Genzyme will remain open until Jan. 21, in a move that will keep the proposed deal alive.", "web_url": "https://dealbook.nytimes.com/2010/12/13/sanofi-extends-genzyme-tender-to-late-january/", "snippet": "Sanofi Aventis says its $69-a-share bid for Genzyme will remain open until Jan. 21, in a move that will keep the proposed deal alive.", "lead_paragraph": "Sanofi Aventis said on Monday that it would extend its $18.5 billion offer for Genzyme until Jan. 21, in a move to keep its proposed deal alive. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sanofi Extends Its $18.5 Billion Genzyme Offer", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Stocks and Bonds", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Genzyme Corp", "rank": 3, "major": "N"}], "pub_date": "2010-12-13T09:11:51+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Chris V. Nicholson", "person": [{"firstname": "Chris", "middlename": "V.", "lastname": "Nicholson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/322ffdb5-dbaa-5838-b7d3-04c49018e1f5", "word_count": 248, "uri": "nyt://article/322ffdb5-dbaa-5838-b7d3-04c49018e1f5"}